Seeing Is Believing
Currently out of the existing stock ratings of Derik De Bruin, 20 are a SELL (17.86%), 43 are a HOLD (38.39%), 49 are a BUY (43.75%).
Analyst Derik De Bruin works at BAML with a stock forecast success ratio of 76.9% fulfilled within 117.8 days on average.
Derik De Bruinās has documented 233 price targets and ratings displayed on 30 stocks. The coverage is on Healthcare, ļ»æBasic Materials sectors.
Most recent stock forecast was given on A, Agilent Technologies at 12-Dec-2023.
Analyst best performing recommendations are on TLIS (TALIS BIOMEDICAL CORP).
The best stock recommendation documented was for TLIS (TALIS BIOMEDICAL CORP) at 3/16/2022. The price target of $22.5 was fulfilled within 2 days with a profit of $3 (15.38%) receiving and performance score of 76.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
170
$39.88 (30.65%)
170
2 months 6 days ago
0/2 (0%)
$29.26 (20.79%)
Sell
80
$-50.12 (-38.52%)
100
2 months 26 days ago
8/9 (88.89%)
$-62.76 (-43.96%)
201
Hold
130
$-0.12 (-0.09%)
120
3 months 4 days ago
2/16 (12.5%)
$-5.14 (-3.80%)
46
Buy
205
4 months 2 days ago
2/5 (40%)
$24.52 (13.59%)
29
Buy
4 months 7 days ago
14/14 (100%)
$-44.76 (-8.87%)
152
Which stock is Derik De Bruin is most bullish on?
Which stock is Derik De Bruin is most reserved on?
What Year was the first public recommendation made by Derik De Bruin?